Quotient Sciences, a drug development and manufacturing accelerator, has completed major investments and expansions at its Nottingham, UK and Reading, UK, facilities to support the delivery of fully integrated drug development programs through the company’s flagship platform, Translational Pharmaceutics.   The new clinical pharmacology space and expanded development laboratories increase the company’s capacity to conduct integrated Translational Pharmaceutics programs for global pharma and bio...